Find Support on Your Journey
Latest News
November 6, 2025
DEFB4A/hBD2, a non-invasive serum biomarker for detection of ulcerative colitis – Nature
November 6, 2025
Daratumumab Approval May Be “Game Changer” in High-Risk Smoldering Myeloma – CancerNetwork
November 6, 2025
Darzalex Faspro® Now FDA-Approved for Patients with High-Risk Smoldering Myeloma
Updated 11/6/2025 The FDA has approved Darzalex Faspro® (a version of daratumumab given as an injection under the skin) for use in certain patients with high-risk smoldering multiple myeloma (SMM). If you’ve been diagnosed with smoldering multiple myeloma—especially if you’ve been told you’re high-risk—you’ve likely wondered: Should I treat my smoldering disease right now, or […]
November 6, 2025
Data Confirm Biosimilar Bmab 1200 Performance in Psoriasis Through 1 Year – Center for Biosimilars
November 6, 2025
Looking for a Clinical Trial?
As of November 8, 2025
1088 Lung Cancer Clinical Trials are now recruiting
846 Breast Cancer Clinical Trials are now recruiting
601 Colorectal Cancer Clinical Trials are now recruiting
443 Prostate Cancer Clinical Trials are now recruiting
433 Pancreatic Cancer Clinical Trials are now recruiting
Source: clinicaltrials.gov